Real-Time PCR Assay for Detection of Fluoroquinolone Resistance Associated with grlA Mutations in Staphylococcus aureus
Open Access
- 1 July 2003
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 41 (7) , 3246-3251
- https://doi.org/10.1128/jcm.41.7.3246-3251.2003
Abstract
Resistance to fluoroquinolones among clinical isolates of Staphylococcus aureus has become a clinical problem. Therefore, a rapid method to identify S. aureus and its susceptibility to fluoroquinolones could provide clinicians with a useful tool for the appropriate use of these antimicrobial agents in the health care settings. In this study, we developed a rapid real-time PCR assay for the detection of S. aureus and mutations at codons Ser-80 and Glu-84 of the grlA gene encoding the DNA topoisomerase IV, which are associated with decreased susceptibility to fluoroquinolones. The detection limit of the assay was 10 genome copies per reaction. The PCR assay was negative with DNA from all 26 non- S. aureus bacterial species tested. A total of 85 S. aureus isolates with various levels of fluoroquinolone resistance was tested with the PCR assay. The PCR assay correctly identified 100% of the S. aureus isolates tested compared to conventional culture methods. The correlation between the MICs of ciprofloxacin, levofloxacin, and gatifloxacin and the PCR results was 98.8%. The total time required for the identification of S. aureus and determination of its susceptibility to fluoroquinolones was about 45 min, including DNA extraction. This new rapid PCR assay represents a powerful method for the detection of S. aureus and its susceptibility to fluoroquinolones.Keywords
This publication has 27 references indexed in Scilit:
- Activity of Quinolones Against Gram-Positive Cocci: Mechanisms of Drug Action and Bacterial ResistanceEuropean Journal of Clinical Microbiology & Infectious Diseases, 2002
- Detection of Ciprofloxacin-Resistant Yersinia pestis by Fluorogenic PCR Using the LightCyclerJournal of Clinical Microbiology, 2001
- Mechanisms and Frequency of Resistance to Gatifloxacin in Comparison to AM-1121 and Ciprofloxacin in Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2001
- Survey of Infections Due toStaphylococcusSpecies: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program, 1997–1999Clinical Infectious Diseases, 2001
- Use of a LightCycler gyrA Mutation Assay for Rapid Identification of Mutations Conferring Decreased Susceptibility to Ciprofloxacin in Multiresistant Salmonella enterica Serotype Typhimurium DT104 IsolatesJournal of Clinical Microbiology, 2001
- Molecular epidemiology of quinolone resistance and comparative in vitro activities of new quinolones against EuropeanStaphylococcus aureusisolatesFEMS Immunology & Medical Microbiology, 1999
- Molecular beacon sequence analysis for detecting drug resistance in Mycobacterium tuberculosisNature Biotechnology, 1998
- Trends in Bacterial Resistance to FluoroquinolonesClinical Infectious Diseases, 1997
- Molecular Beacons: Probes that Fluoresce upon HybridizationNature Biotechnology, 1996
- Efflux-mediated fluoroquinolone resistance in Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1993